Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Radiotherapy Side Effect
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 21 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04340024
- Collaborators
- National Medical Research Council (NMRC), Singapore
- Duke-NUS Graduate Medical School
- Ferring Pharmaceuticals
- ImmunoSCAPE
- Decipher Biosciences
- Investigators
- Principal Investigator: Melvin Chua, MD National Cancer Centre, Singapore
Get Well Soon